Cinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
Cipla USA, Inc. is recalling Cinacalcet Hydrochloride 90 mg tablets (Lot #5PB0563, expiring 4/30/2027) distributed nationwide due to the presence of N-nitroso-cinacalcet above acceptable daily intake levels, a manufacturing deviation.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a prescription drug with an impurity (N-nitroso compound) above acceptable intake thresholds. Per the rubric, FDA Class II with manufacturing deviations that pose potential health risk meets the Severe criterion, even though no illnesses have been reported.
Plain-English summary
Cipla USA, Inc. is recalling Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottles (NDC 69097-412-02) due to current Good Manufacturing Practice (cGMP) deviations. The recalled lot (Lot #5PB0563, expiration date 4/30/2027) contains N-nitroso-cinacalcet at levels above the acceptable daily intake.
Cinacalcet is a prescription medication used to treat certain conditions related to calcium and parathyroid hormone levels. Patients currently taking this product should not stop taking their medication without consulting their healthcare provider. Consumers with questions or who have experienced any adverse effects should contact their healthcare provider or pharmacist.
The product was distributed nationwide. Cipla USA, Inc., located at 10 Independence Boulevard, Suite 300, Warren, NJ 07059, is conducting this recall. The FDA has classified this as a Class II recall.
The recalled product
- Product
- CINACALCET (CINACALCET)
- Brand
- CINACALCET
- Manufacturer
- Cipla USA, Inc.
- Category
- Drug — Prescription Tablet
- Hazard
- impurity
- n-nitroso-cinacalcet
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 5PB0563
- Exp 4/30/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CINACALCET
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding FDA Safety Limit
FDA (Drugs) · 2024-12-11
- HighFDA Recalls Cinacalcet 30mg Tablets for N-nitroso Impurity
FDA (Drugs) · 2024-12-11
- HighPrescription Cinacalcet Tablets Recalled for N-Nitroso Impurity
FDA (Drugs) · 2024-12-11
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereChloraPrep One-Step Antiseptic Applicators recalled for lack of sterility assurance
FDA (Drugs) · 2026-07-08
- SevereAccucaine Lidocaine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Sterile Solution Lacks Assurance of Sterility
FDA (Drugs) · 2026-07-08
- ModerateMedline Convenience Kits Block Tray recalled due to quality defects
FDA (Devices) · 2026-07-08